Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Diagnosis of alcohol use disorders in schizophrenia
The Therapeutic Goods Administration's (TGA) warning covers the following glucagon-like peptide-1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and obesity: Semaglutide, sold as Ozempic, Wegovy Tirzepatide, sold as Mounjaro Dulaglutide, sold as Trulicity Liraglutide, sold as Saxenda The TGA said the products had the potential to cause an eye disorder called non-arteritic anterior ischaemic optic neuropathy (NAION)
doi: 10.1111/and.13162 66 NieschlagEBoulouxPGStegmannBJShankarRRGuanYTzontchevaAet al
Obviously, this is an exaggeration, but it is kind of how it looks
US$ 24.78
US$ 26.11
US$ 26.37
US$ 21.38
US$ 21.50
US$ 20.45
US$ 26.60
